Provider
QP64-25 Commercial Pharmacy Benefit Exclusion for Enflonsia™, Imuldosa™, Osenvelt®, Stoboclo®, Yeztugo® and Zusduri™
Program effective Date: Aug 13, 2025
Program effective Date: Aug 13, 2025
Program effective Date: Aug 13, 2025
Program effective Date: Aug 13, 2025
Program effective Date: Aug 13, 2025
Program effective Date: Aug 13, 2025
Examen De Detección De Cáncer De Cuello Uterino (De 21 A Los 64 Años)
Qho Kev Kuaj Tshuaj Xyuas Tus Mob Khees Xaws Rau Lub Ncauj Tsev Me Nyuam (Hnub Nyoog 21 Txog 64 Xyoos)